TB-500 human tolerability studies report mild adverse events at doses up to 1,260 mg [5] [11]
RGN-352 was shown to be safe and well-tolerated with no serious drug-related adverse events reported (PMID: 20536472) Phase 2 AMI trial (incomplete): RegeneRx designed a Phase 2 proof-of-concept trial (NCT01311518) to evaluate RGN-352 in approximately 75 patients with acute ST-segment elevation myocardial infarction (heart attack)
GH and IGF-1 operate via generalized anabolic stimulation and mitogenesis, whereas BPC-157 appears to favor modulation of the tissue microenvironment (local angiogenesis, controlled inflammation, endothelial stabilization)
If the solution is cloudy or has particles, do not use it
Don't let excess weight hold you back any longer take the first step toward a healthier, happier you.
Individual peptide pricing breakdown Let us get specific